CHUN-KAI HUANGJEI-YIE HUANGChang, Chin-HaoChin-HaoChangTsai, Shang-JieShang-JieTsaiCHIN-CHUNG SHUHAO-CHIEN WANGKUO-LIONG CHIEN2024-04-262024-04-262024-04-0816841182https://scholars.lib.ntu.edu.tw/handle/123456789/642110Tuberculosis (TB) remains prevalent worldwide, and anti-TB drugs are associated with drug-induced liver injury (DILI). Statins have pleiotropic effects which may decrease inflammation and achieve immunomodulation. However, few studies have investigated the pleiotropic effects of statins on the risk of DILI. The purpose of this study was to investigate whether statins prevent anti-tuberculosis DILI among active TB patients on standard anti-TB drug therapy.enAnti-tuberculosis drug; Drug-induced liver injury; Statin; Tuberculosis[SDGs]SDG3journal article10.1016/j.jmii.2024.04.002386320212-s2.0-85190506134https://api.elsevier.com/content/abstract/scopus_id/85190506134